Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study-Reference-Cited by-同舟云学术

Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study

Published:2013 Issue:3 Volume:130 Page:199-205
ISSN:1421-9662
Container-title:Acta Haematologica
language:en
Short-container-title:Acta Haematol

Author:

Buyukasik Yahya,Acar Kadir,Kelkitli Engin,Uz Burak,Serefhanoglu Songul,Ozdemir Evren,Pamukcuoglu Merve,Atay Hilmi,Bektas Ozlen,Sucak Gulsan Turkoz,Turgut Mehmet,Aksu Salih,Yagci Munci,Sayinalp Nilgun,Ozcebe Osman I.,Goker Hakan,Haznedaroglu Ibrahim C.

Publisher

S. Karger AG

Subject

Hematology,General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase;Hematology;2024-03-25

2. Prognostic Factors and Outcome of Patients with Adult Acute Lymphoblastic Leukemia Treated with the Hyper-CVAD Regimen: A Retrospective Study;Advances in Hematology;2023-11-09

3. AraC interacts with p75NTR transmembrane domain to induce cell death of mature neurons;Cell Death & Disease;2023-07-17

4. Higher Survival Advantage With Hyper-CVAD Chemotherapy Regimen Before Allogeneic Stem Cell Transplantation In Patients With High Risk Adult Acute Lymphoblastic Leukemia: Two-Center Experience;Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi;2022-08-20

5. Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center;Leukemia Research;2022-08